(Chicago – May 21, 2012) The Pharmaceutical Business Intelligence Research Group (PBIRG) today awarded Galileo Analytics Co-Founder and CEO Simon Fitall with the 2012 Mary Clement Lifetime Achievement Award, one of the most prestigious honors within the life science market research and business intelligence industry.
Fitall was selected by representatives from PBIRG and the pharmaceutical industry to receive the award, which recognizes outstanding lifetime contributions to the pharmaceutical industry and the market research profession. To be considered, nominees must demonstrate outstanding character and ethics; dedication to their companies, colleagues and PBIRG; superior expertise in developing and executing market research, business intelligence projects and methodologies; and dedication to the betterment of the market research profession.
The annual award, which was presented at the PBIRG Annual General Meeting in Chicago, is issued in honor of researcher Mary Clement, a respected PBIRG member who died of cancer in 2001.
PBIRG is a not-for-profit industry association dedicated to the advancement of global healthcare marketing research, business intelligence and strategic planning in theory and practice.